202 – Successful Regulatory Relationships Post-COVID-19 with Sponsors and FDRs
Learning Objectives:
Changes from COVID-19 on the regulatory relationship: more virtual, government has less resources, more expectations on Health Plans to comply and step up, more regulator sensitivity to CTMs due to beneficiary financial issues
Changes to Health Plan workforce: More remote- how to reach, teach, and enforce compliance in virtual settings, privacy issues, and security of data/workspaces in the “new normal”
Impacts to daily work and operations: FDRs impacted by shifting supply chain dynamics, applicability of COVID-19 additional and evolving regulations, and how to operationalize them in this new dynamic
Speakers:
Robert Alfano, Director of Compliance Services, Prime Therapeutics LLC